Joint Extraintestinal Manifestations in Ulcerative Colitis

被引:20
作者
Dorofeyev, A. E. [1 ]
Vasilenko, I. V. [1 ]
Rassokhina, O. A. [1 ]
机构
[1] Natl Med Univ, Donetsk, Ukraine
关键词
Colon mucosal barrier; Cytokine disturbances; Extraintestinal manifestations; pathogenic mechanisms; Joint manifestations; Ulcerative colitis; joint manifestations; INFLAMMATORY-BOWEL-DISEASE; PREVALENCE;
D O I
10.1159/000233289
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
An extraintestinal manifestation (EIM) very often occurs in ulcerative colitis (UC) patients. EIM modifies the natural course of UC and decreases the quality of life in these patients. The aim of this study was to analyze clinical and laboratory findings in UC patients with joint EIM. 319 UC patients were examined. Among them were 131 (41.1%) patients with distal UC, 102 (32.0%) suffered from left-sided UC and 86 (26.9%) had pancolitis. 95 (29.8%) UC patients had joint EIM. Arthritis correlated with extensive forms of UC and was more often determined in patients with left-sided UC and pancolitis. Arthralgia was a prevalent symptom of joint EIM in patients with distal UC. Colon microbiocenosis and the mucosal barrier in UC patients were analyzed. The cytokine status with privileged cytokine profile changes was investigated. In all UC patients, dysbiosis with a decreasing quantity of bifidobacteria, lactobacilli and Escherichia coli was found, but an increase of facultative flora was also found. At the same time, an association of facultative flora in UC patients with arthritis was observed. In these patients, Staphylococcus, Klebsiella and Proteus were found more often in stool cultures. These associations correlated with a modification of the colonocytes' cell receptor maturity of mucus, a condition with a decreased staining intensity by lectins. A cytokine imbalance with an increase of proinflammatory and a decrease of anti-inflammatory cytokines was found in all UC patients. The privileged cytokine profile changes in UC patients with joint EIM were analyzed. Maximal increases of IL-1 and TNF with decreases of IL-10 in plasma in patients with joint EIM were observed. Copyright (C) 2009 S. Karger AG, Basel
引用
收藏
页码:502 / 510
页数:9
相关论文
共 18 条
  • [1] Bernstein CN, 2001, AM J GASTROENTEROL, V96, P1116
  • [2] The clustering of other chronic inflammatory diseases in inflammatory bowel disease: A population-based study
    Bernstein, CN
    Wajda, A
    Blanchard, JF
    [J]. GASTROENTEROLOGY, 2005, 129 (03) : 827 - 836
  • [3] Extraintestinal manifestations in inflammatory bowel disease
    Danese, Silvio
    Semeraro, Stefano
    Papa, Alfredo
    Roberto, Italia
    Scaldaferri, Franco
    Fedeli, Giuseppe
    Gasbarrini, Giovanni
    Gasbarrini, Antonio
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2005, 11 (46) : 7227 - 7236
  • [4] de Vlam K, 2000, J RHEUMATOL, V27, P2860
  • [5] Review article: joint involvement in inflammatory bowel disease
    De Vos, M
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2004, 20 : 36 - 42
  • [6] Immunomodulatory effects of etanercept on peripheral joint synovitis in the spondylarthropathies
    Kruithof, E
    De Rycke, L
    Roth, J
    Mielants, H
    Van den Bosch, F
    De Keyser, F
    Veys, EM
    Baeten, D
    [J]. ARTHRITIS AND RHEUMATISM, 2005, 52 (12): : 3898 - 3909
  • [7] Loginov AS, 2000, INTESTINAL DISEASES, P137
  • [8] LUTSYK MD, 1981, LECTINS VISHCHA SHKO, P114
  • [9] Mendoza JL, 2005, MED CLIN-BARCELONA, V125, P297
  • [10] NESVIZHSKY YV, 1995, ARCH CLIN EXP MED, V4, P175